The fund is constantly included in 2-6 investment rounds annually. The usual things for fund are deals in the range of 5 - 10 millions dollars. The top activity for fund was in 2019. Considering the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations.
The usual cause for the fund is to invest in rounds with 3-4 partakers. The meaningful sponsors for the fund in investment in the same round are muru-D, Transition Level Investments, Seven West Media.
Among the most successful fund investment fields, there are Energy, Natural Language Processing. Among the various public portfolio startups of the fund, we may underline Starts at 60, Kira Biotech Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups.
Related Funds
| Fund Name | Location |
| Bay Capital | India, Maharashtra, Mumbai |
| BioMotiv | Cleveland, Ohio, United States |
| Huazhang Jiye Equity Investment Fund Management | China, Guangdong, Shenzhen |
| Investopedia | Manhattan, New York, United States |
| LEO Group | China, Wenling, Zhejiang |
| Master Ventures | China, Hong Kong, Hong Kong Island |
| Mitsubishi UFJ Lease and Finance | Chiyoda, Japan |
| Multicoin Capital | Austin, Texas, United States |
| Revcap | England, London, United Kingdom |
| S4 Holdings | - |
| Schneider Electric Ventures | California, Menlo Park, United States |
| Shanghai Guangya Touzi | China, Shanghai |
| Shanghai Yifeng Xinxi | China, Shanghai |
| Southern Capitol Ventures | North Carolina, Raleigh, United States |
| StarTec Investments | Minneapolis, Minnesota, United States |
| Twenty Five Ventures | California, San Francisco, United States |
| Varia Ventures | Buffalo, New York, United States |
| Vencore Capital | Lake Oswego, Oregon, United States |
| Walden Ventures | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
| $600K | 09 Jun 2020 | Cairns, Queensland, Australia | |||
Kira Biotech | $20M | 28 Oct 2019 | Maine, United States | ||
Kapiche | $1M | 03 Sep 2019 | Brisbane City, Queensland, Australia | ||
| $4M | 12 Aug 2019 | Brisbane City, Queensland, Australia |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
| $600K | 09 Jun 2020 | Cairns, Queensland, Australia | |||
Kira Biotech | $20M | 28 Oct 2019 | Maine, United States | ||
Kapiche | $1M | 03 Sep 2019 | Brisbane City, Queensland, Australia | ||
| $4M | 12 Aug 2019 | Brisbane City, Queensland, Australia |
